Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity
OBJECTIVE: Schizophrenia is a neurodegenerative and neurodevelopmental disorder. For this reason, it is important to determine the level of markers that are neuroprotective and have been altered in other neurodegenerative diseases in inspecting the etiology of schizophrenia. Secretagogin (SCGN), is...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mesut Çetin
2019-10-01
|
| Serier: | Psychiatry and Clinical Psychopharmacology |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/24750573.2019.1589175 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|